An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell Carcinoma

NCT01351571 · clinicaltrials.gov ↗
COMPLETED
Status
5
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hoffmann-La Roche